SOMERVILLE KURT F - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
SOMERVILLE KURT F ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$258,000
-62.6%
5,079
-70.4%
0.05%
-63.7%
Q1 2017$689,000
-48.2%
17,131
-38.3%
0.15%
-50.5%
Q4 2016$1,331,000
+22.2%
27,781
-6.6%
0.30%
+24.5%
Q3 2016$1,089,000
+50.8%
29,741
-4.3%
0.24%
+46.3%
Q2 2016$722,000
-39.5%
31,076
+5.4%
0.16%
-40.7%
Q1 2016$1,194,000
-32.9%
29,476
+2.6%
0.27%
-32.8%
Q4 2015$1,779,00028,7260.41%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Bellevue Group AG 9,347,926$313,529,0003.18%
Sicart Associates LLC 291,254$9,769,0002.66%
Camber Capital Management LP 2,500,000$83,850,0002.58%
SECTOR GAMMA AS 263,870$8,850,0001.76%
Parkman Healthcare Partners LLC 136,380$4,574,0001.16%
Eversept Partners, LP 450,501$15,109,8041.05%
SPHERA FUNDS MANAGEMENT LTD. 350,000$11,739,0000.99%
TANAKA CAPITAL MANAGEMENT INC 16,661$559,0000.80%
Sonora Investment Management, LLC 163,703$5,491,0000.69%
ARK Investment Management 8,511,384$285,472,0000.69%
View complete list of IONIS PHARMACEUTICALS INC shareholders